TELA Bio, Inc.
TELA· Nasdaq
TELATELA Bio, Inc.
Filed May 14, 2021 · 10-Q · 44 days after period end · 0001558370-21-007229
| Metric | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|
| Revenue | $5.88M | $3.73M | $3.31M |
| Net Income | -$8.14M | -$7.22M | -$5.97M |
| EPS Diluted | -$0.56 | -$0.63 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TELA Bio, Inc. · CIK 1561921 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 14, 2021 · 44 d after period end
